Laura and John Arnold Foundation Report issue

Foundation Phase 4

Organization Overview

First Clinical Trial
2014
NCT02334215
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Laura and John Arnold Foundation